| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1132aafe0114c430d873af38f3c2bd2a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-8128 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81 |
| filingDate |
2000-05-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a85cb2421c818b29c23a7f3d8012d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62cb20e8f0e06b9487a4ff0cc346a80a |
| publicationDate |
2002-04-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1194033-A1 |
| titleOfInvention |
Transgenically produced antithrombin iii and mutants thereof |
| abstract |
The invention features transgenically produced mutants of Antithrombin III, e.g., transgenically produced mutants of ATIII having enhanced antiangiogenic activity. The invention also features methods of making mutants of ATIII, and transgenic organisms which express a mutated ATIII. |
| priorityDate |
1999-05-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |